Nanobiotix S.A. (NBTX) Q4 2023 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Nanobiotix Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.029 -- 00:00:05.634 Good day and welcome to the Nanobiotics Business Update and Full Year 2023 00:00:05.634 -- 00:00:11.278 Financial Results Conference Call. At this time, all participants are in a listen-only 00:00:11.278 -- 00:00:17.003 mode. After the speaker's presentation, there will be a question and answer session. 00:00:17.003 -- 00:00:20.706 Please be advised that today's conference is being recorded. 00:00:20.706 -- 00:00:25.730 At this point, I will now turn the call over to Craig West, Senior Vice President 00:00:25.730 -- 00:00:30.560 of Investor Relations of Nanobiotics. Please go ahead. 00:00:30.560 -- 00:00:35.564 Thank you. Good afternoon, good morning, and welcome to the Nanobiotics Conference 00:00:35.564 -- 00:00:41.089 call to discuss our full year 2023 financial and operating results. 00:00:41.089 -- 00:00:46.513 Joining me on the call today are Laurent Levy, co-founder and chief executive officer, 00:00:46.513 -- 00:00:49.596 and Bart Van Ryn, chief financial officer. 00:00:49.596 -- 00:00:54.039 As a reminder, today's call is being webcast and will be available on our website for 00:00:54.039 -- 00:00:55.440 replay. 00:00:55.440 -- 00:00:59.566 I would like to remind you that this call will include forward-looking statements, which 00:00:59.566 -- 00:01:04.708 may include statements regarding the progress, success and timing of our ongoing and 00:01:04.708 -- 00:01:09.750 planned clinical trials, collaborations, regulatory filings, 00:01:09.750 -- 00:01:15.812 dates of presentation and future research and development efforts, among other things. 00:01:15.812 -- 00:01:21.234 These forward-looking statements are based on current information, assumptions and expectations 00:01:21.234 -- 00:01:27.214 that are subject to change. Th...